Lataa...
Precision Treatment in ACS–Role of Assessing Fibrinolysis
Despite advancements in pharmacotherapy and interventional strategies, patients with acute coronary syndrome (ACS) remain at risk of recurrent thrombotic events. In addition to an enhanced tendency to thrombus formation, impairment in the ability to naturally dissolve or lyse a developing thrombus,...
Tallennettuna:
| Julkaisussa: | J Clin Med |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7957496/ https://ncbi.nlm.nih.gov/pubmed/33804303 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10050929 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|